Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) to start with the second line of disease-modifying
therapy (DMT), a lower percentage would choose dimethyl
as control: Their right eyes were left without wound healing
therapy, while the left eyes received